{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T13:49:00Z","timestamp":1785419340525,"version":"3.56.0"},"reference-count":64,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T00:00:00Z","timestamp":1716422400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["por-journal.com"],"crossmark-restriction":true},"short-container-title":["Pathol. Oncol. Res."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Acquired Hemophilia A (AHA) is a rare autoimmune disorder characterized by the emergence of inhibitors that specifically target coagulation Factor VIII, frequently resulting in severe bleeding episodes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted a retrospective analysis of the medical records of a 68-year-old male patient who presented with adalimumab-induced AHA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The patient received adalimumab, a tumor necrosis factor inhibitor antibody, as part of his treatment for rheumatoid arthritis. The patient\u2019s clinical journey, characterized by intense bleeding and coagulopathy, was effectively managed with the application of recombinant Factor VIIa (rFVIIa) and the CyDRi protocol.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>The case emphasizes the importance of prompt coagulation assessment in patients with bleeding symptoms receiving disease-modifying therapy for rheumatoid arthritis that includes adalimumab therapy, considering the rare yet life-threatening nature of AHA. Additionally, this report provides an extensive review of the existing literature on drug-induced AHA, with a special emphasis on cases linked to immunomodulatory medications. Through this two-pronged approach, our report aims to enhance understanding and awareness of this severe complication among healthcare providers, promoting timely diagnosis and intervention.<\/jats:p><\/jats:sec>","DOI":"10.3389\/pore.2024.1611720","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T04:11:52Z","timestamp":1716437512000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Case Report: Effective management of adalimumab-induced acquired hemophilia A with the CyDRI protocol"],"prefix":"10.3389","volume":"30","author":[{"given":"Andrea","family":"Cegl\u00e9di","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1rp\u00e1d","family":"B\u00e1tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e1nos","family":"Dolgos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nika","family":"Fekete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e1szl\u00f3","family":"Gopcsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikt\u00f3ria","family":"Kir\u00e1ly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gergely","family":"Lakatos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gy\u00f6rgy","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsuzsanna","family":"Szemlaky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"V\u00e1rkonyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Be\u00e1ta","family":"Vilimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e1bor","family":"Mikala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imre","family":"Bod\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,5,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1111\/j.1538-7836.2012.04654.x","article-title":"Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)","volume":"10","author":"Knoebl","year":"2012","journal-title":"J Thromb Haemost"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1182\/blood-2006-06-029850","article-title":"Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom haemophilia centre doctors' organisation","volume":"109","author":"Collins","year":"2007","journal-title":"Blood"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1111\/hae.14845","article-title":"Acquired haemophilia A: a 15-year population-based review of incidence rate, patient demographics and treatment outcomes","volume":"29","author":"Tian","year":"2023","journal-title":"Haemophilia"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e383","DOI":"10.1111\/hae.13598","article-title":"Retrospective review of Acquired Haemophilia A from the largest Canadian Haemophilia treatment centre","volume":"24","author":"Jayakar","year":"2018","journal-title":"Haemophilia"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e466","DOI":"10.1111\/hae.14149","article-title":"The rising incidence of acquired haemophilia A in Germany","volume":"27","author":"Tiede","year":"2021","journal-title":"Haemophilia"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1111\/1346-8138.13468","article-title":"Acquired hemophilia A and fulminant diabetes mellitus possibly caused by adalimumab in a patient with psoriatic arthritis","volume":"44","author":"Yamaguchi","year":"2017","journal-title":"J Dermatol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1080\/09273948.2020.1808227","article-title":"Adalimumab-associated acquired hemophilia in a patient with scleritis","volume":"30","author":"Liberman","year":"2022","journal-title":"Ocul Immunol Inflamm"},{"key":"B8","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1097\/RHU.0b013e31823ee3cd","article-title":"Fatal acquired hemophilia A in a patient with rheumatoid arthritis treated with adalimumab","volume":"18","author":"Arthanari","year":"2012","journal-title":"J Clin Rheumatol"},{"key":"B9","first-page":"RA55","article-title":"Drug-induced anti-factor VIII antibodies: a systematic review","volume":"13","author":"Franchini","year":"2007","journal-title":"Med Sci Monit"},{"key":"B10","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/hae.14692","article-title":"Drug-associated acquired hemophilia A: an analysis based on 185 cases from the WHO pharmacovigilance database","volume":"29","author":"Konstantinov","year":"2023","journal-title":"Haemophilia"},{"key":"B11","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1136\/bmj.329.7461.323","article-title":"Acquired haemophilia A may be associated with clopidogrel","volume":"329","author":"Haj","year":"2004","journal-title":"BMJ"},{"key":"B12","doi-asserted-by":"publisher","first-page":"80","DOI":"10.5045\/kjh.2012.47.1.80","article-title":"A patient with acquired hemophilia A induced by clopidogrel","volume":"47","author":"Hwang","year":"2012","journal-title":"Korean J Hematol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"bcr2018226588","DOI":"10.1136\/bcr-2018-226588","article-title":"Development of acquired haemophilia A in a patient treated with alemtuzumab for multiple sclerosis","volume":"2018","author":"Madeley","year":"2018","journal-title":"BMJ Case Rep"},{"key":"B14","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.msard.2018.11.029","article-title":"Acquired haemophilia A as a secondary autoimmune disease after alemtuzumab treatment in multiple sclerosis: a case report","volume":"27","author":"Pisa","year":"2019","journal-title":"Mult Scler Relat Disord"},{"key":"B15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/bjh.16644","article-title":"Acquired haemophilia A after alemtuzumab treatment of multiple sclerosis","volume":"190","author":"Brink","year":"2020","journal-title":"Br J Haematol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e337","DOI":"10.1111\/hae.14107","article-title":"Acquired haemophilia A after alemtuzumab therapy","volume":"26","author":"van der Zwan","year":"2020","journal-title":"Haemophilia"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e000095","DOI":"10.1136\/bmjno-2020-000095","article-title":"Two case reports of acquired haemophilia A as complications of alemtuzumab treatment for multiple sclerosis","volume":"3","author":"Gounder","year":"2021","journal-title":"BMJ Neurol Open"},{"key":"B18","doi-asserted-by":"publisher","first-page":"3271","DOI":"10.1007\/s00277-023-05370-8","article-title":"Alemtuzumab induced acquired hemophilia A in multiple sclerosis: a case report","volume":"102","author":"Fawaz","year":"2023","journal-title":"Ann Hematol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.annder.2020.09.577","article-title":"Onset of acquired haemophilia A after omalizumab treatment in severe bullous pemphigoid - a report on two cases successfully treated with mycophenolate mofetil","volume":"148","author":"Mangin","year":"2021","journal-title":"Ann Dermatol Venereol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1097\/MBC.0b013e32832fb1b9","article-title":"Acquired factor VIII inhibitors: case reports of paclitaxel and penicillin-induced entities","volume":"20","author":"El-Osta","year":"2009","journal-title":"Blood Coagul Fibrinolysis"},{"key":"B21","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s12185-017-2273-6","article-title":"First report of real-time monitoring of coagulation function potential and IgG subtype of anti-FVIII autoantibodies in a child with acquired hemophilia A associated with streptococcal infection and amoxicillin","volume":"107","author":"Takeyama","year":"2018","journal-title":"Int J Hematol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1046\/j.1365-2516.2002.00574.x","article-title":"Acquired anti-FVIII inhibitors in children","volume":"8","author":"Moraca","year":"2002","journal-title":"Haemophilia"},{"key":"B23","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1179\/102453311X12902908412156","article-title":"Factor VIII and IX deficiencies related to acquired inhibitors in a patient with chronic hepatitis C virus infection receiving treatment with pegylated interferon plus ribavirin","volume":"16","author":"Campos-de-Magalhaes","year":"2011","journal-title":"Hematology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.thromres.2011.04.014","article-title":"Acquired factor VIII inhibitor as presentation of chronic myelogenous leukemia during interferon-alpha therapy","volume":"128","author":"Zheng","year":"2011","journal-title":"Thromb Res"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e73","DOI":"10.1111\/j.1365-2516.2012.02775.x","article-title":"Acquired haemophilia in a patient treated with interferon-\u03b1 for hepatitis C infection","volume":"18","author":"Goyal","year":"2012","journal-title":"Haemophilia"},{"key":"B26","doi-asserted-by":"publisher","first-page":"ED21","DOI":"10.7860\/JCDR\/2017\/21598.10109","article-title":"Acquired inhibitor of factor VIII presenting as delayed wound healing","volume":"11","author":"Nayar","year":"2017","journal-title":"J Clin Diagn Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1345\/aph.1E100","article-title":"Severe acquired hemophilia with factor VIII inhibition associated with acetaminophen and chlorpheniramine","volume":"38","author":"Famularo","year":"2004","journal-title":"Ann Pharmacother"},{"key":"B28","doi-asserted-by":"publisher","first-page":"102181","DOI":"10.1016\/j.msard.2020.102181","article-title":"Acquired hemophilia A and other autoimmune diseases after alemtuzumab therapy for multiple sclerosis: a report of two cases","volume":"44","author":"Comini-Frota","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"B29","doi-asserted-by":"publisher","first-page":"bcr2017223016","DOI":"10.1136\/bcr-2017-223016","article-title":"Acquired haemophilia A complicating alemtuzumab therapy for multiple sclerosis","volume":"2017","author":"McCaughan","year":"2017","journal-title":"BMJ Case Rep"},{"key":"B30","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.msard.2019.07.016","article-title":"B cell depletion therapy resulting in sustained remission of severe autoimmune complications following Alemtuzumab treatment of Multiple Sclerosis","volume":"35","author":"Massey","year":"2019","journal-title":"Mult Scler Relat Disord"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e239","DOI":"10.1016\/j.jtho.2018.06.024","article-title":"Nivolumab-induced hemophilia A presenting as gastric ulcer bleeding in a patient with nsclc","volume":"13","author":"Kato","year":"2018","journal-title":"J Thorac Oncol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e560","DOI":"10.1016\/j.cllc.2019.06.022","article-title":"Acquired hemophilia A after nivolumab therapy in a patient with metastatic squamous cell carcinoma of the lung successfully managed with rituximab","volume":"20","author":"Gokozan","year":"2019","journal-title":"Clin Lung Cancer"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.3390\/diagnostics12102559","article-title":"A diagnostic of acquired hemophilia following PD1\/PDL1 inhibitors in advanced melanoma: the experience of two patients and a literature review","volume":"12","author":"Gidaro","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"B34","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.jbspin.2014.12.003","article-title":"Acquired hemophilia possibly induced by etanercept in a patient with rheumatoid arthritis","volume":"82","author":"Banse","year":"2015","journal-title":"Jt Bone Spine"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1007\/s11357-022-00515-5","article-title":"Age-dependent frequency of unconventional T cells in a healthy adult Caucasian population: a combinational study of invariant natural killer T cells, \u03b3\u03b4 T cells, and mucosa-associated invariant T cells","volume":"44","author":"Singh","year":"2022","journal-title":"Geroscience"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1007\/s11357-022-00536-0","article-title":"Senescent macrophages in the human adipose tissue as a source of inflammaging","volume":"44","author":"Matacchione","year":"2022","journal-title":"Geroscience"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s11357-020-00208-x","article-title":"Poor mitochondrial health and systemic inflammation? Test of a classic hypothesis in the Baltimore Longitudinal Study of Aging","volume":"42","author":"Zampino","year":"2020","journal-title":"Geroscience"},{"key":"B38","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1007\/s11357-023-00913-3","article-title":"Exposome and unhealthy aging: environmental drivers from air pollution to occupational exposures","volume":"45","author":"Pandics","year":"2023","journal-title":"Geroscience"},{"key":"B39","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s11357-022-00698-x","article-title":"Multiple myeloma, a quintessential malignant disease of aging: a geroscience perspective on pathogenesis and treatment","volume":"45","author":"Urban","year":"2023","journal-title":"Geroscience"},{"key":"B40","doi-asserted-by":"publisher","first-page":"16372","DOI":"10.3390\/ijms242216372","article-title":"Key genes of the immune system and predisposition to acquired hemophilia A: evidence from a Spanish cohort of 49 patients using next-generation sequencing","volume":"24","author":"Pardos-Gea","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B41","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1365-2516.2008.01976.x","article-title":"HLA genotype in patients with acquired haemophilia A","volume":"16","author":"Pavlova","year":"2010","journal-title":"Haemophilia"},{"key":"B42","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/j.1365-2516.2007.01618.x","article-title":"Increased frequency of the CTLA-4 49 A\/G polymorphism in patients with acquired haemophilia A compared to healthy controls","volume":"14","author":"Pavlova","year":"2008","journal-title":"Haemophilia"},{"key":"B43","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1365-2516.2010.02259.x","article-title":"Genetic markers in acquired haemophilia","volume":"16","author":"Oldenburg","year":"2010","journal-title":"Haemophilia"},{"key":"B44","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1517\/14740338.4.4.637","article-title":"Adalimumab: a review of side effects","volume":"4","author":"Scheinfeld","year":"2005","journal-title":"Expert Opin Drug Saf"},{"key":"B45","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/MIB.0000000000000981","article-title":"Sex is associated with adalimumab side effects and drug survival in patients with Crohn's disease","volume":"23","author":"Lie","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1179547619858979","DOI":"10.1177\/1179547619858979","article-title":"Fulminant herpes simplex hepatitis secondary to adalimumab in Crohn's disease: a case report","volume":"12","author":"Goel","year":"2019","journal-title":"Clin Med Insights Case Rep"},{"key":"B47","doi-asserted-by":"publisher","first-page":"375","DOI":"10.2147\/BTT.S317888","article-title":"Adalimumab therapy in a patient with psoriasis, down syndrome, and concomitant hepatitis B virus infection","volume":"15","author":"Madani","year":"2021","journal-title":"Biologics"},{"key":"B48","first-page":"239","article-title":"Adalimumab-associated multiple sclerosis","volume":"34","author":"Bensouda-Grimaldi","year":"2007","journal-title":"J Rheumatol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s10067-012-2113-2","article-title":"New-onset multiple sclerosis associated with adalimumab treatment in rheumatoid arthritis: a case report and literature review","volume":"32","author":"Matsumoto","year":"2013","journal-title":"Clin Rheumatol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00296-012-2625-8","article-title":"Multiple sclerosis during adalimumab treatment in a case with ankylosing spondylitis","volume":"34","author":"Uygunoglu","year":"2014","journal-title":"Rheumatol Int"},{"key":"B51","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1007\/s00296-021-04995-0","article-title":"Demyelinating disease (multiple sclerosis) in a patient with psoriatic arthritis treated with adalimumab: a case-based review","volume":"41","author":"Baresic","year":"2021","journal-title":"Rheumatol Int"},{"key":"B52","doi-asserted-by":"publisher","first-page":"342","DOI":"10.29399\/npa.27973","article-title":"Multiple sclerosis - like demyelinating lesions during adalimumab treatment in a case with Crohn's disease","volume":"59","author":"Sokmen","year":"2022","journal-title":"Noro Psikiyatr Ars"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1080\/09273948.2022.2113800","article-title":"Multiple sclerosis in a patient with intermediate uveitis and juvenile idiopathic arthritis treated with adalimumab: a case report","volume":"31","author":"Rojas-Carabali","year":"2023","journal-title":"Ocul Immunol Inflamm"},{"key":"B54","doi-asserted-by":"publisher","first-page":"e929148","DOI":"10.12659\/AJCR.929148","article-title":"Fatal new-onset congestive heart failure related to adalimumab use in a patient with relapsing hidradenitis suppurativa: a case report","volume":"22","author":"Mansito Lopez","year":"2021","journal-title":"Am J Case Rep"},{"key":"B55","doi-asserted-by":"publisher","first-page":"38","DOI":"10.5414\/cpp49038","article-title":"Subacute liver failure induced by adalimumab","volume":"49","author":"Hagel","year":"2011","journal-title":"Int J Clin Pharmacol Ther"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.2169\/internalmedicine.54.3433","article-title":"Autoimmune hemolytic anemia during adalimumab treatment for plaque psoriasis","volume":"54","author":"Harada","year":"2015","journal-title":"Intern Med"},{"key":"B57","doi-asserted-by":"publisher","first-page":"715","DOI":"10.2169\/internalmedicine.55.5773","article-title":"Autoimmune hemolytic anemia induced by adalimumab","volume":"55","author":"Nagashima","year":"2016","journal-title":"Intern Med"},{"key":"B58","doi-asserted-by":"publisher","first-page":"e13711","DOI":"10.1111\/dth.13711","article-title":"Adalimumab-induced hemolytic anemia in a girl with psoriasis","volume":"33","author":"Sanchez-Pujol","year":"2020","journal-title":"Dermatol Ther"},{"key":"B59","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/ajh.26009","article-title":"Treatment of acquired hemophilia A, a balancing act: results from a 27-year Dutch cohort study","volume":"96","author":"Schep","year":"2021","journal-title":"Am J Hematol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"e19145","DOI":"10.7759\/cureus.19145","article-title":"Management of acquired factor VIII inhibitors with NovoSeven and obizur","volume":"13","author":"Miatech","year":"2021","journal-title":"Cureus"},{"key":"B61","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/ajh.24777","article-title":"Acquired hemophilia A: updated review of evidence and treatment guidance","volume":"92","author":"Kruse-Jarres","year":"2017","journal-title":"Am J Hematol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1182\/blood-2014-07-587089","article-title":"Prognostic factors for remission of and survival in acquired hemophilia A (AHA): results from the GTH-AH 01\/2010 study","volume":"125","author":"Tiede","year":"2015","journal-title":"Blood"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1182\/blood.2022016873","article-title":"Combined immunosuppression for acquired hemophilia A: CyDRi is a highly effective low-toxicity regimen","volume":"140","author":"Simon","year":"2022","journal-title":"Blood"},{"key":"B64","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1182\/blood-2012-02-409185","article-title":"Immunosuppression for acquired hemophilia A: results from the European acquired haemophilia registry (EACH2)","volume":"120","author":"Collins","year":"2012","journal-title":"Blood"}],"container-title":["Pathology and Oncology Research"],"original-title":[],"link":[{"URL":"https:\/\/www.por-journal.com\/articles\/10.3389\/pore.2024.1611720\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T04:11:57Z","timestamp":1716437517000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.por-journal.com\/articles\/10.3389\/pore.2024.1611720\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,23]]},"references-count":64,"alternative-id":["10.3389\/pore.2024.1611720"],"URL":"https:\/\/doi.org\/10.3389\/pore.2024.1611720","relation":{},"ISSN":["1532-2807"],"issn-type":[{"value":"1532-2807","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,23]]},"article-number":"1611720"}}